Daniel E. Geffken - Mar 20, 2023 Form 4 Insider Report for CalciMedica, Inc. (CALC)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CALC	Warrant	Award		+11.5K			11.5K	Mar 20, 2023	Common Stock	11.5K	$6.60	By SG Dan Equity Holdings, LLC	F1, F2
transaction	CALC	Warrant	Award		+5.76K			5.76K	Mar 20, 2023	Common Stock	5.76K	$10.42	By SG Dan Equity Holdings, LLC	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Immediately exercisable.
F2	Received in exchange for a warrant to acquire 400,000 shares of common stock of CalciMedica, Inc. ("CalciMedica") pursuant to an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among CalciMedica, the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the "Merger"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each outstanding warrant to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into a warrant to purchase the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc.
F3	Received in exchange for a warrant to purchase 200,000 shares of common stock of CalciMedica pursuant to the Merger Agreement. Upon the closing of the Merger, each outstanding warrant to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into a warrant to purchase the Issuer's common stock